| pubmed-article:8111758 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8111758 | lifeskim:mentions | umls-concept:C1704259 | lld:lifeskim |
| pubmed-article:8111758 | lifeskim:mentions | umls-concept:C1705987 | lld:lifeskim |
| pubmed-article:8111758 | lifeskim:mentions | umls-concept:C0850292 | lld:lifeskim |
| pubmed-article:8111758 | lifeskim:mentions | umls-concept:C0449445 | lld:lifeskim |
| pubmed-article:8111758 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:8111758 | pubmed:dateCreated | 1994-3-30 | lld:pubmed |
| pubmed-article:8111758 | pubmed:abstractText | Aim of this study is to suggest our methodological approach for transcatheter ablation of Kent bundles by radiofrequency energy as to the potential ablation sites, the need in unipolar or bipolar recording mode, single catheter or multiple catheters mapping of anomalous pathways, the vascular approach for both left sited and right sited anomalous pathways, and finally the duration and power to supply. The recording of Kent potential and/or a Va-QRS interval > or = 0 ms have been considered significant predictors of success (respectively p < 0.001 and p < 0.05). The unipolar recording mode has been considered critical in the choice of ablation site in 47 (29.9%) patients. A 6-catheter approach for both diagnostic electrophysiologic studies and mapping allowed us to easily localize accessory pathways and to record either a probable or possible Kent potential in a high percentage of patients and to reduce the permanence of the ablation catheter in the left ventricle. By transaortic retrograde approach in ablating left sited anomalous pathways, we obtained a high success rate, while right sited accessory pathway were approached from the inferior vena cava. In right sited anomalous pathway we delivered radiofrequency energy for a longer time in order to avoid a relapse soon after the procedure. We performed ablation of 174/178 (97.7%) anomalous pathways in 165/169 (97.6%) patients. We observed a 3.8% relapse during a mean follow up of 13 +/- 9 months. | lld:pubmed |
| pubmed-article:8111758 | pubmed:language | ita | lld:pubmed |
| pubmed-article:8111758 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8111758 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8111758 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8111758 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:8111758 | pubmed:issn | 0393-1978 | lld:pubmed |
| pubmed-article:8111758 | pubmed:author | pubmed-author:ChiarielloMM | lld:pubmed |
| pubmed-article:8111758 | pubmed:author | pubmed-author:De SimoneAA | lld:pubmed |
| pubmed-article:8111758 | pubmed:author | pubmed-author:LambertiFF | lld:pubmed |
| pubmed-article:8111758 | pubmed:author | pubmed-author:SantomauroMM | lld:pubmed |
| pubmed-article:8111758 | pubmed:author | pubmed-author:PapponeCC | lld:pubmed |
| pubmed-article:8111758 | pubmed:author | pubmed-author:StabileGG | lld:pubmed |
| pubmed-article:8111758 | pubmed:author | pubmed-author:SenatoreGG | lld:pubmed |
| pubmed-article:8111758 | pubmed:author | pubmed-author:LoricchioM... | lld:pubmed |
| pubmed-article:8111758 | pubmed:author | pubmed-author:FranciosaPP | lld:pubmed |
| pubmed-article:8111758 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8111758 | pubmed:volume | 38 | lld:pubmed |
| pubmed-article:8111758 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8111758 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8111758 | pubmed:pagination | 651-60 | lld:pubmed |
| pubmed-article:8111758 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:meshHeading | pubmed-meshheading:8111758-... | lld:pubmed |
| pubmed-article:8111758 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8111758 | pubmed:articleTitle | [A methodological approach to the transcatheter radiofrequency ablation of anomalous Kent-type pathways]. | lld:pubmed |
| pubmed-article:8111758 | pubmed:affiliation | Dipartimento di Cardiologia e Cardiochirurgia, II Facoltà di Medicina e Chirurgia, Università degli Studi Federico II, Napoli. | lld:pubmed |
| pubmed-article:8111758 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8111758 | pubmed:publicationType | English Abstract | lld:pubmed |
